Ádám Póti

1.1k total citations
32 papers, 697 citations indexed

About

Ádám Póti is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ádám Póti has authored 32 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ádám Póti's work include DNA Repair Mechanisms (11 papers), CRISPR and Genetic Engineering (8 papers) and Cancer Genomics and Diagnostics (6 papers). Ádám Póti is often cited by papers focused on DNA Repair Mechanisms (11 papers), CRISPR and Genetic Engineering (8 papers) and Cancer Genomics and Diagnostics (6 papers). Ádám Póti collaborates with scholars based in Hungary, United States and Denmark. Ádám Póti's co-authors include Dávid Szüts, Bernadett Szikriszt, Zoltán Szállási, Orsolya Pipek, István Csabai, Charles Swanton, Marcin Krzystanek, Dezső Ribli, Eszter Németh and Andrea L. Richardson and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The EMBO Journal.

In The Last Decade

Ádám Póti

32 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ádám Póti Hungary 15 469 214 197 117 73 32 697
Kenjiro Asagoshi Japan 17 952 2.0× 233 1.1× 182 0.9× 87 0.7× 58 0.8× 24 1.1k
Nicholas T. Woods United States 17 614 1.3× 137 0.6× 236 1.2× 110 0.9× 58 0.8× 40 858
Fernando F. Blanco United States 16 583 1.2× 284 1.3× 293 1.5× 48 0.4× 43 0.6× 25 1.0k
Pingfang Liu United States 17 833 1.8× 252 1.2× 104 0.5× 93 0.8× 67 0.9× 23 980
Andreas Roidl Germany 15 636 1.4× 247 1.2× 206 1.0× 31 0.3× 33 0.5× 27 817
Mariska C. de Jong Netherlands 9 613 1.3× 170 0.8× 338 1.7× 75 0.6× 50 0.7× 10 848
Nilanjana Chatterjee United States 12 765 1.6× 98 0.5× 118 0.6× 40 0.3× 51 0.7× 33 967

Countries citing papers authored by Ádám Póti

Since Specialization
Citations

This map shows the geographic impact of Ádám Póti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ádám Póti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ádám Póti more than expected).

Fields of papers citing papers by Ádám Póti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ádám Póti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ádám Póti. The network helps show where Ádám Póti may publish in the future.

Co-authorship network of co-authors of Ádám Póti

This figure shows the co-authorship network connecting the top 25 collaborators of Ádám Póti. A scholar is included among the top collaborators of Ádám Póti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ádám Póti. Ádám Póti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Póti, Ádám, et al.. (2024). Mutational profile of the regenerative process and de novo genome assembly of the planarian Schmidtea polychroa. Nucleic Acids Research. 52(4). 1779–1792. 2 indexed citations
2.
Lózsa, Rita, Ádám Póti, Eszter Németh, et al.. (2024). Comprehensive investigation of the mutagenic potential of six pesticides classified by IARC as probably carcinogenic to humans. Chemosphere. 362. 142700–142700. 8 indexed citations
3.
4.
Kiss, Ádám, et al.. (2023). Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients. International Journal of Molecular Sciences. 24(17). 13380–13380. 3 indexed citations
5.
Póti, Ádám, et al.. (2023). Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein–Protein Binding. International Journal of Molecular Sciences. 24(19). 14854–14854. 4 indexed citations
6.
Tóth, Katalin, et al.. (2023). CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. Scientific Reports. 13(1). 18507–18507. 11 indexed citations
7.
Póti, Ádám, Eszter Németh, Bernadett Szikriszt, et al.. (2023). Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL. Cell Reports. 42(8). 112887–112887. 12 indexed citations
8.
Németh, Eszter, Ádám Póti, Nataliya Petryk, et al.. (2022). Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers. Cell Reports. 38(12). 110555–110555. 30 indexed citations
9.
Zeke, András, Tamás Takács, Krisztina Németh, et al.. (2022). Structural insights into the pSer/pThr dependent regulation of the SHP2 tyrosine phosphatase in insulin and CD28 signaling. Nature Communications. 13(1). 5439–5439. 6 indexed citations
10.
Alexa, Anita, Fridolin Groß, Ádám Póti, et al.. (2022). A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host. Nature Communications. 13(1). 472–472. 15 indexed citations
11.
Chiroli, Elena, Fridolin Groß, Ádám Póti, et al.. (2021). Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization. The EMBO Journal. 40(22). e108225–e108225. 12 indexed citations
12.
Zeke, András, Orsolya Tőke, Ashish Sethi, et al.. (2020). Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38. Nature Communications. 11(1). 5769–5769. 39 indexed citations
13.
Róna, Gergely, Lőrinc Sándor Pongor, Gábor Papp, et al.. (2020). Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments. eLife. 9. 14 indexed citations
14.
Kudlik, Gyöngyi, Kornélia Szebényi, Nóra Kucsma, et al.. (2020). Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line. International Journal of Molecular Sciences. 21(4). 1185–1185. 11 indexed citations
15.
Kovács, Gábor M., Ádám Póti, Attila Reményi, et al.. (2019). High‐throughput competitive fluorescence polarization assay reveals functional redundancy in the S100 protein family. FEBS Journal. 287(13). 2834–2846. 26 indexed citations
16.
Póti, Ádám, Eszter Németh, Orsolya Rusz, et al.. (2019). Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. Genome biology. 20(1). 240–240. 72 indexed citations
17.
Póti, Ádám, Yonghong Xiao, Orsolya Pipek, et al.. (2018). Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. British Journal of Cancer. 119(11). 1392–1400. 22 indexed citations
18.
Pipek, Orsolya, Dezső Ribli, J. Molnár, et al.. (2017). Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut. BMC Bioinformatics. 18(1). 73–73. 22 indexed citations
19.
Szikriszt, Bernadett, Ádám Póti, Orsolya Pipek, et al.. (2016). A comprehensive survey of the mutagenic impact of common cancer cytotoxics. Genome biology. 17(1). 99–99. 128 indexed citations
20.
Zámborszky, Judit, Bernadett Szikriszt, Orsolya Pipek, et al.. (2016). Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions. Oncogene. 36(6). 746–755. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenjiro Asagoshi Breakdown of academic impact, for papers by Nicholas T. Woods Breakdown of academic impact, for papers by Fernando F. Blanco Breakdown of academic impact, for papers by Pingfang Liu Breakdown of academic impact, for papers by Andreas Roidl Breakdown of academic impact, for papers by Mariska C. de Jong Breakdown of academic impact, for papers by Nilanjana Chatterjee
Rankless by CCL
2026